BRPI0511290A - composições e métodos referentes aos inibidores da sìntese da pirimidina - Google Patents

composições e métodos referentes aos inibidores da sìntese da pirimidina

Info

Publication number
BRPI0511290A
BRPI0511290A BRPI0511290-7A BRPI0511290A BRPI0511290A BR PI0511290 A BRPI0511290 A BR PI0511290A BR PI0511290 A BRPI0511290 A BR PI0511290A BR PI0511290 A BRPI0511290 A BR PI0511290A
Authority
BR
Brazil
Prior art keywords
compositions
subject
pyrimidine synthesis
dependente
virus infection
Prior art date
Application number
BRPI0511290-7A
Other languages
English (en)
Inventor
Sadis Matalon
Ian C Davis
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of BRPI0511290A publication Critical patent/BRPI0511290A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSIçõES E MéTODOS REFERENTES AOS INIBIDORES DA SìNTESE DA PIRIMIDINA. A presente invenção se refere às composições que compreendem um inibidor da síntese da pirimidina e um carreador farmaceuticamente aceitável. Tais composições podem ser usadas em métodos para aumentar o clearance líquido dependente de Na¬ +¬ por uma célula pulmonar epitelial; para o tratamento de uma doença pulmonar em um individuo; para reduzir um ou mais sintomas ou sinais físicos de uma infecção pelo vírus sincicial respiratório em um indivíduo; para a identificação de um indivíduo em risco de infecção pelo vírus sincicial respiratório e a administração ao indivíduo de uma composição compreendendo uma quantidade eficaz de um inibidor de pirimidina; para a identificação de um indivíduo com infecção pelo vírus sincicial respiratório e a administração ao indivíduo de uma composição compreendendo um inibidor da síntese de pirimidina em uma quantidade eficaz para reduzir o líquido alveolar dependente de Na¬ +¬ para um rastreamento de um composto teste que aumenta a captação do líquido dependente de Na¬ +¬ por uma célula epitelial pulmonar.
BRPI0511290-7A 2004-05-21 2005-05-20 composições e métodos referentes aos inibidores da sìntese da pirimidina BRPI0511290A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57355804P 2004-05-21 2004-05-21
PCT/US2005/017939 WO2006001961A2 (en) 2004-05-21 2005-05-20 Compositions and methods relating to pyrimidine synthesis inhibitors

Publications (1)

Publication Number Publication Date
BRPI0511290A true BRPI0511290A (pt) 2007-12-18

Family

ID=35782230

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511290-7A BRPI0511290A (pt) 2004-05-21 2005-05-20 composições e métodos referentes aos inibidores da sìntese da pirimidina

Country Status (10)

Country Link
US (1) US20070219224A1 (pt)
EP (1) EP1763346A4 (pt)
JP (1) JP2008500393A (pt)
KR (1) KR20070044399A (pt)
CN (1) CN1993125A (pt)
AU (1) AU2005257862A1 (pt)
BR (1) BRPI0511290A (pt)
CA (1) CA2567602A1 (pt)
MX (1) MXPA06013435A (pt)
WO (1) WO2006001961A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
EP2100881A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Pyrimidyl- or pyridinylaminobenzoic acid derivatives
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (en) 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combination comprising DHODH inhibitors and methotrexate
EP2228367A1 (en) 2009-03-13 2010-09-15 Almirall, S.A. Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors
EP2239256A1 (en) 2009-03-13 2010-10-13 Almirall, S.A. Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
EP2230232A1 (en) 2009-03-13 2010-09-22 Almirall, S.A. Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
EP2314577A1 (en) 2009-10-16 2011-04-27 Almirall, S.A. Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid
US8686048B2 (en) 2010-05-06 2014-04-01 Rhizen Pharmaceuticals Sa Immunomodulator and anti-inflammatory compounds
EP2672963A4 (en) 2011-02-08 2015-06-24 Childrens Medical Center METHOD FOR THE TREATMENT OF MELANOMA
CN108721281A (zh) * 2017-04-20 2018-11-02 华东理工大学 新的抗病毒药物及其应用
US20220296594A1 (en) * 2019-05-08 2022-09-22 Massachusetts Institute Of Technology Potentiators of antimicrobial and/or antiviral agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174219T1 (de) * 1993-01-08 1998-12-15 Hoechst Ag Verwendung von leflunomid zur hemmung von tumornekrosefaktor alpha
US7691890B2 (en) * 1998-03-11 2010-04-06 James W. Williams Anti-viral uses of leflunomide products
CZ301802B6 (cs) * 1999-03-19 2010-06-30 Vertex Pharmaceuticals Incorporated Deriváty mocoviny jako inhibitory IMPDH a farmaceutické prostredky s jejich obsahem
WO2001072298A1 (en) * 2000-03-27 2001-10-04 The General Hospital Corporation Treatments for immune-mediated ear disorders
MXPA04000224A (es) * 2001-07-10 2005-07-25 4Sc Ag Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos.
EP1539693B9 (en) * 2002-06-19 2008-10-08 Schering Corporation Cannabinoid receptor agonists

Also Published As

Publication number Publication date
EP1763346A4 (en) 2009-03-04
WO2006001961A2 (en) 2006-01-05
CA2567602A1 (en) 2006-01-05
CN1993125A (zh) 2007-07-04
EP1763346A2 (en) 2007-03-21
US20070219224A1 (en) 2007-09-20
WO2006001961A3 (en) 2006-09-14
MXPA06013435A (es) 2007-03-23
AU2005257862A1 (en) 2006-01-05
JP2008500393A (ja) 2008-01-10
KR20070044399A (ko) 2007-04-27

Similar Documents

Publication Publication Date Title
BRPI0713367A2 (pt) composto, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação de plaqueta
BRPI0516105A (pt) composições de fator de crescimento derivado de plaqueta e métodos de uso destas
ATE538774T1 (de) Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionen
BRPI0507877A (pt) derivados de formamida, composição farmacêutica, uso dos mesmos e combinação
MX384206B (es) Formulaciones de inhibidores de dpp iv
BRPI0609121B8 (pt) 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2
BR112012009214A2 (pt) compostos
BRPI0510273A (pt) derivados de tetraazabenzo[e]azuleno e análogos destes
BRPI0818657A8 (pt) Composições adesivas contendo reticuladores
BRPI0921482A8 (pt) Uso de uma construção de anticorpo de cadeia simples biespecífica cd19xcd3 no tratamento de leucemia linfoblástica aguda
BRPI0716483B8 (pt) compostos inibidores do vírus da hepatite c e composição farmacêutica que os compreende
BRPI0717156B8 (pt) inibidores do co-transportador 2 da glicose de sódio e composição farmacêutica que os compreende
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
BRPI0713357A2 (pt) Inibidores de proteína tirosina fosfatase humana e método de utilização.
BRPI0613962A2 (pt) inibidores macrocìclicos inovadores de replicação de vìrus da hepatite c
BRPI0911681B8 (pt) composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula in vitro
BRPI0806400A8 (pt) composto, composição farmacêutica, produtos, usos de pelo menos um composto, método in vitro, kit, ligantes e processo de preparação de um composto
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.
AR056047A1 (es) Derivados de bencil - benceno sustituidos con glucopiranosilo, medicamentos que contienen dichos compuestos, su uso y procedimiento para su preparacion.
BRPI0911469A8 (pt) Inibidores de gm-csf e il-17 para terapia
WO2006001961A3 (en) Compositions and methods relating to pyrimidine synthesis inhibitors
BRPI0606437A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação de plaqueta
CN115475171A (zh) 一种具有抗冠状病毒活性的化合物及其应用
Yang et al. Thrombopoietin levels increased in patients with severe acute respiratory syndrome
BRPI0507435A (pt) compostos de piperidinilcarbonilpirrolidinas, processos para a preparação do mesmo,composição farmacêutica e uso como agonistas de melanocortina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.